Cardiovascular

RSS

Endothelin antagonist claimed by Roche

June 21, 1996

U.K. restriction of sotalol hydrochloride

June 14, 1996

Antiarrhythmic agents from Merck & Co.

June 14, 1996

ITMR system phase II trial expansion granted

June 14, 1996

Selective PDGF inhibitors revealed

June 14, 1996

More Na+/H+-exchange inhibitors from E. Merck

June 14, 1996

Na+/H+-exchange inhibitors from Sumitomo

June 14, 1996

Cardiovascular disorders treatment from Boryung Pharm.

June 14, 1996

Merck & Co. discloses endothelin antagonists

June 14, 1996

Endothelin antagonists from Abbott

June 14, 1996